134 related articles for article (PubMed ID: 10778991)
1. The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts.
Weitman S; Marty J; Jolivet J; Locas C; Von Hoff DD
Clin Cancer Res; 2000 Apr; 6(4):1574-8. PubMed ID: 10778991
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.
Damaraju VL; Bouffard DY; Wong CK; Clarke ML; Mackey JR; Leblond L; Cass CE; Grey M; Gourdeau H
BMC Cancer; 2007 Jul; 7():121. PubMed ID: 17608948
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.
Gourdeau H; Clarke ML; Ouellet F; Mowles D; Selner M; Richard A; Lee N; Mackey JR; Young JD; Jolivet J; Lafrenière RG; Cass CE
Cancer Res; 2001 Oct; 61(19):7217-24. PubMed ID: 11585758
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity.
Gourdeau H; Bibeau L; Ouellet F; Custeau D; Bernier L; Bowlin T
Cancer Chemother Pharmacol; 2001 Mar; 47(3):236-40. PubMed ID: 11320667
[TBL] [Abstract][Full Text] [Related]
6. Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma.
Lam W; Bussom S; Cheng YC
Mol Cancer Ther; 2009 Feb; 8(2):415-23. PubMed ID: 19208827
[TBL] [Abstract][Full Text] [Related]
7. Troxacitabine prodrugs for pancreatic cancer.
Adema AD; Radi M; Daft J; Narayanasamy J; Hoebe EK; Alexander LE; Chu CK; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1073-7. PubMed ID: 18058539
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the L-stereoisomeric nucleoside analog troxacitabine for the treatment of acute myeloid leukemia.
Quintás-Cardama A; Cortes J
Expert Opin Investig Drugs; 2007 Apr; 16(4):547-57. PubMed ID: 17371201
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of troxacitabine in chemotherapy-naive patients with advanced cancer of the pancreas: gastrointestinal tumors.
Lapointe R; Létourneau R; Steward W; Hawkins RE; Batist G; Vincent M; Whittom R; Eatock M; Jolivet J; Moore M
Ann Oncol; 2005 Feb; 16(2):289-93. PubMed ID: 15668286
[TBL] [Abstract][Full Text] [Related]
10. Troxacitabine: BCH 4556, SPD 758, Troxatyl.
Adis International Ltd
Drugs R D; 2003; 4(4):264-8. PubMed ID: 12848594
[TBL] [Abstract][Full Text] [Related]
11. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.
Kadhim SA; Bowlin TL; Waud WR; Angers EG; Bibeau L; DeMuys JM; Bednarski K; Cimpoia A; Attardo G
Cancer Res; 1997 Nov; 57(21):4803-10. PubMed ID: 9354442
[TBL] [Abstract][Full Text] [Related]
12. Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia.
Giles FJ; Cortes JE; Baker SD; Thomas DA; O'Brien S; Smith TL; Beran M; Bivins C; Jolivet J; Kantarjian HM
J Clin Oncol; 2001 Feb; 19(3):762-71. PubMed ID: 11157029
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenografts.
Schultz RM; Merriman RL; Toth JE; Zimmermann JE; Hertel LW; Andis SL; Dudley DE; Rutherford PG; Tanzer LR; Grindey GB
Oncol Res; 1993; 5(6-7):223-8. PubMed ID: 8123942
[TBL] [Abstract][Full Text] [Related]
14. A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma.
Vose JM; Panwalkar A; Belanger R; Coiffier B; Baccarani M; Gregory SA; Facon T; Fanin R; Caballero D; Ben-Yehuda D; Giles F
Leuk Lymphoma; 2007 Jan; 48(1):39-45. PubMed ID: 17325846
[TBL] [Abstract][Full Text] [Related]
15. Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluation.
Orsolic N; Giles FJ; Gourdeau H; Golemovic M; Beran M; Cortes J; Freireich EJ; Kantarjian H; Verstovsek S
Br J Haematol; 2004 Mar; 124(6):727-38. PubMed ID: 15009060
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group.
Townsley CA; Chi K; Ernst DS; Belanger K; Tannock I; Bjarnason GA; Stewart D; Goel R; Ruether JD; Siu LL; Jolivet J; McIntosh L; Seymour L; Moore MJ;
J Clin Oncol; 2003 Apr; 21(8):1524-9. PubMed ID: 12697876
[TBL] [Abstract][Full Text] [Related]
17. Cellular resistance against troxacitabine in human cell lines and pediatric patient acute myeloid leukemia blast cells.
Adema AD; Zuurbier L; Floor K; Hubeek I; Kaspers GJ; Albertoni F; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):981-6. PubMed ID: 17065050
[TBL] [Abstract][Full Text] [Related]
18. The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine.
Lam W; Leung CH; Bussom S; Cheng YC
Mol Pharmacol; 2007 Sep; 72(3):536-44. PubMed ID: 17565005
[TBL] [Abstract][Full Text] [Related]
19. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
[TBL] [Abstract][Full Text] [Related]
20. Troxacitabine (Shire Pharmaceuticals).
Ecker G
Curr Opin Investig Drugs; 2002 Oct; 3(10):1533-8. PubMed ID: 12431032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
